Allosteric effects on substrate dissociation from cytochrome P450 3A4 in nanodiscs observed by ensemble and single-molecule fluorescence spectroscopy
- PMID: 18980315
- PMCID: PMC2649694
- DOI: 10.1021/ja805772r
Allosteric effects on substrate dissociation from cytochrome P450 3A4 in nanodiscs observed by ensemble and single-molecule fluorescence spectroscopy
Abstract
Cytochrome P450 (CYP) 3A4 is a major human drug-metabolizing enzyme and displays pharmacologically relevant allosteric kinetics caused by multiple substrate and/or effector binding. Here, in the first single-molecule (SM) fluorescence studies of CYPs, we use total internal reflection fluorescence microscopy to measure residence times of the fluorescent dye Nile Red in CYP3A4 incorporated in surface-immobilized lipid Nanodiscs, with and without the effector alpha-naphthoflavone. We find direct evidence that CYP3A4 effectors can decrease substrate off-rates, providing a possible mechanism for effector-mediated enhancement of substrate metabolism. These interesting results highlight the potential of SM methods in studies of CYP allosteric mechanisms.
Figures
Similar articles
-
Nile Red is a fluorescent allosteric substrate of cytochrome P450 3A4.Biochemistry. 2008 Jan 15;47(2):509-16. doi: 10.1021/bi7013807. Epub 2007 Dec 20. Biochemistry. 2008. PMID: 18092806
-
Analysis of heterotropic cooperativity in cytochrome P450 3A4 using alpha-naphthoflavone and testosterone.J Biol Chem. 2011 Feb 18;286(7):5540-5. doi: 10.1074/jbc.M110.182055. Epub 2010 Dec 22. J Biol Chem. 2011. PMID: 21177853 Free PMC article.
-
Allosteric activation of cytochrome P450 3A4 by α-naphthoflavone: branch point regulation revealed by isotope dilution analysis.Biochemistry. 2011 Nov 22;50(46):10041-51. doi: 10.1021/bi2013454. Epub 2011 Oct 28. Biochemistry. 2011. PMID: 22004098 Free PMC article.
-
Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture.J Inorg Biochem. 2017 Feb;167:100-115. doi: 10.1016/j.jinorgbio.2016.11.025. Epub 2016 Nov 25. J Inorg Biochem. 2017. PMID: 27919007 Review.
-
Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems.Dalton Trans. 2013 Mar 7;42(9):3116-26. doi: 10.1039/c2dt31833d. Epub 2012 Sep 27. Dalton Trans. 2013. PMID: 23018626 Free PMC article. Review.
Cited by
-
Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.Adv Exp Med Biol. 2015;851:83-105. doi: 10.1007/978-3-319-16009-2_3. Adv Exp Med Biol. 2015. PMID: 26002732 Free PMC article. Review.
-
Characterization of de novo synthesized GPCRs supported in nanolipoprotein discs.PLoS One. 2012;7(9):e44911. doi: 10.1371/journal.pone.0044911. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23028674 Free PMC article.
-
Drug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4.Biochemistry. 2018 Feb 6;57(5):805-816. doi: 10.1021/acs.biochem.7b01012. Epub 2017 Dec 14. Biochemistry. 2018. PMID: 29200287 Free PMC article.
-
Nanodiscs in the studies of membrane-bound cytochrome P450 enzymes.Methods Mol Biol. 2013;987:115-27. doi: 10.1007/978-1-62703-321-3_10. Methods Mol Biol. 2013. PMID: 23475672 Free PMC article.
-
Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.Biochemistry. 2019 Mar 12;58(10):1411-1422. doi: 10.1021/acs.biochem.8b01268. Epub 2019 Feb 28. Biochemistry. 2019. PMID: 30785734 Free PMC article.
References
-
- Thummel KE, Wilkinson GR. Annu Rev Pharmacol Toxicol. 1998;38:389–430. - PubMed
-
- Atkins WM. Expert Opin Drug Metab Toxicol. 2006;2(4):573–9. - PubMed
-
- Khan KK, He YQ, Domanski TL, Halpert JR. Mol Pharmacol. 2002;61(3):495–506. - PubMed
-
- Isin EM, Guengerich FP. J Biol Chem. 2006;281(14):9127–36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources